Jetro Emanel Ang

Jetro Emanel Ang

Auto-generated profile, based on publicly available information

Jetro Emanel Ang

Department of Psychiatry, Melbourne Medical School, The University of Melbourne, Melbourne, Australia

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2023 in Journal of the American Academy of Child & Adolescent Psychiatry
Verified
Journal Article
Closed access
AFAmy Finlay-Jones
Amy Finlay-Jones
JAJetro Emanel Ang
Jetro Emanel Ang
JBJuliet Brook
Juliet Brook
JLJayden D. Lucas
Jayden D. Lucas
LMLeigha A. MacNeill
Leigha A. MacNeill
LWLauren S. Wakschlag
Lauren S. Wakschlag

6 October 2026 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
JAJetro E. Ang
Jetro E. Ang
YXYangqi Xu
Yangqi Xu
VCVanessa Cropley
Vanessa Cropley
AZAndrew Zalesky
Andrew Zalesky
YTYe Ella Tian
Ye Ella Tian

3 August 2026 in medRxiv
Verified
Preprint
Open access
PDF file
JAJetro E Ang
Jetro E Ang
YXYangqi Xu
Yangqi Xu
VCVanessa Cropley
Vanessa Cropley
AZAndrew Zalesky
Andrew Zalesky
YTYe Ella Tian
Ye Ella Tian
Background Although mental illness is primarily regarded as a disorder of the brain, body system dysfunction is increasingly recognized as a salient biomarker in psychiatry, often emerging before the onset of overt symptoms. Here, we systematically review studies on peripheral organ systems (cardiovascular, metabolic, immune, liver, kidneys, lungs and muskeloskeletal) in schizophrenia, major depressive disorder (MDD), bipolar disorder (BD) and generalized anxiety disorder (GAD), aiming to synthesize findings on the function of multiple body systems in the early stages of mental illness. Methods EMBASE, MEDLINE and PsycINFO were searched from inception until 19 November 2024, identifying case-control studies comparing physiological markers of peripheral organ systems (i.e., cardiovascular, metabolic, immune, liver, kidney, lung and muskeloskeletal) in adults with one of the four mental illnesses at first-episode and drug naive, with healthy controls. We followed the PRISMA 2020 guidelines (PROSPERO: CRD42023408594). Results Of 2,637 citations retrieved, 138 studies met inclusion criteria for review with 52 markers of immune (n=32), metabolic (n=11), cardiovascular (n=6), liver (n=2) and musculoskeletal (n=1) function identified. 105 studies were eligible for meta-analysis, including 80, 26, 4 and 0 studies on schizophrenia, MDD, BD and GAD respectively. Meta-analysis revealed increased HDL-cholesterol, waist-hip-circumference ratio, triglycerides, insulin, insulin resistance, 2-hr glucose, neutrophil, monocyte, white blood cell, IL-4 and systolic blood pressure, and reduced albumin in schizophrenia; increased TNF-α and IL-10 in MDD; and increased IL-6 and IFN-γ in both schizophrenia and MDD. Other results were narratively discussed. Conclusions Alterations in peripheral organ function across multiple systems characterizes the onset of psychiatric disorders. However, research on peripheral organ function in psychiatry is limited and primarily focusses on the immune and metabolic systems.

16 September 2026 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
JAJetro E. Ang
Jetro E. Ang
YXYangqi Xu
Yangqi Xu
VCVanessa Cropley
Vanessa Cropley
AZAndrew Zalesky
Andrew Zalesky
YTYe Ella Tian
Ye Ella Tian
Background: Although mental illness is primarily regarded as a disorder of the brain, body system dysfunction is increasingly recognized as a salient biomarker in psychiatry, often emerging before the onset of overt symptoms. Here, we systematically review studies on peripheral organ systems (cardiovascular, metabolic, immune, liver, kidneys, lungs and muskeloskeletal) in schizophrenia, major depressive disorder (MDD), bipolar disorder (BD) and generalized anxiety disorder (GAD), aiming to synthesize findings on the function of multiple body systems in the early stages of mental illness. Methods: EMBASE, MEDLINE and PsycINFO were searched from inception until 19 November 2024, identifying case-control studies comparing physiological markers of peripheral organ systems (i.e., cardiovascular, metabolic, immune, liver, kidney, lung and muskeloskeletal) in adults with one of the four mental illnesses at first-episode and drug naive, with healthy controls. We followed the PRISMA 2020 guidelines (PROSPERO: CRD42023408594). Results: Of 2637 citations retrieved, 138 studies met inclusion criteria for review with 52 markers of immune ( n = 32), metabolic ( n = 11), cardiovascular ( n = 6), liver ( n = 2) and musculoskeletal ( n = 1) function identified. 105 studies were eligible for meta-analysis, including 80, 26, 4 and 0 studies on schizophrenia, MDD, BD and GAD respectively. Meta-analysis revealed increased waist-hip-circumference ratio, triglycerides, insulin, insulin resistance, 2-hr glucose, neutrophil, monocyte, white blood cell, IL-4 and systolic blood pressure, and reduced albumin in schizophrenia; increased TNF-α and IL-10 in MDD; and increased IL-6 and IFN-γ in both schizophrenia and MDD. Other results were narratively discussed. Conclusions: Alterations in peripheral organ function across multiple systems characterizes the onset of psychiatric disorders. However, research on peripheral organ function in psychiatry is limited and primarily focusses on the immune and metabolic systems.